| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |